Loading...
Loading...
Vascular Solutions, Inc.
VASC announced today that it has filed a patent infringement
complaint in the U.S. District Court for the District of Minnesota against
Boston Scientific Corporation
BSX. The complaint alleges that Boston
Scientific has infringed three patents owned by Vascular Solutions concerning
rapid exchange guide extension technology by manufacturing and selling its
Guidezilla™ guide extension catheter which received 510(k) clearance in March
2013. Vascular Solutions is seeking an injunction against Boston Scientific
prohibiting the manufacture and sale of its Guidezilla catheter as well as
damages for lost profits and legal costs.
U.S. Patents 8,048,032, 8,142,413 and 8,292,850, comprising 60 claims in total
and having an initial filing date of May 2006, were issued by the U.S. Patent
& Trademark Office to Howard Root, et. al. and assigned to Vascular Solutions
concerning rapid exchange guide extension technology. These patents form the
basis for Vascular Solutions' GuideLiner® catheter, the first and until now
only rapid exchange mother-and-child guide extension catheter. Since its
launch in 2009, the GuideLiner catheter has been described by prominent
interventional cardiologists as an "indispensable tool," a "game-changing
device," and a catheter that "makes impossible cases possible."
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in